Synovus Financial Corp Astrazeneca PLC Transaction History

Synovus Financial Corp

  • $7.79 Billion
  • Q4 2024

A detailed history of Synovus Financial Corp transactions in Astrazeneca PLC stock. As of the latest transaction made, Synovus Financial Corp holds 62,716 shares of AZN stock, worth $4.61 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
62,716
Previous 64,860 3.31%
Holding current value
$4.61 Million
Previous $5.05 Million 18.68%
% of portfolio
0.05%
Previous 0.06%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025
SELL
$63.2 - $79.58 $135,500 - $170,619
-2,144 Reduced 3.31%
62,716 $4.11 Million
Q3 2024

Nov 14, 2024
SELL
$76.67 - $87.62 $307,216 - $351,093
-4,007 Reduced 5.82%
64,860 $5.05 Million
Q2 2024

Aug 13, 2024
SELL
$66.81 - $80.83 $72,355 - $87,538
-1,083 Reduced 1.55%
68,867 $5.37 Million
Q1 2024

May 14, 2024
SELL
$61.03 - $69.57 $4.86 Million - $5.54 Million
-79,620 Reduced 53.23%
69,950 $4.74 Million
Q3 2023

Nov 13, 2023
SELL
$64.85 - $71.7 $371,071 - $410,267
-5,722 Reduced 3.68%
149,570 $10.1 Million
Q2 2023

Aug 08, 2023
BUY
$69.91 - $75.81 $141,777 - $153,742
2,028 Added 1.32%
155,292 $11.1 Million
Q1 2023

May 11, 2023
BUY
$63.15 - $71.6 $122,447 - $138,832
1,939 Added 1.28%
153,264 $10.6 Million
Q4 2022

Feb 06, 2023
BUY
$54.21 - $70.44 $84,025 - $109,182
1,550 Added 1.03%
151,325 $10.3 Million
Q3 2022

Oct 27, 2022
BUY
$53.02 - $135.75 $298,184 - $763,458
5,624 Added 3.9%
149,775 $8.2 Million
Q2 2022

Aug 10, 2022
BUY
$59.26 - $71.14 $605,400 - $726,766
10,216 Added 7.63%
144,151 $9.53 Million
Q1 2022

May 12, 2022
BUY
$55.72 - $67.12 $184,600 - $222,368
3,313 Added 2.54%
133,935 $8.89 Million
Q4 2021

Feb 14, 2022
BUY
$54.02 - $63.83 $373,332 - $441,129
6,911 Added 5.59%
130,622 $7.61 Million
Q3 2021

Nov 08, 2021
BUY
$55.56 - $60.79 $175,958 - $192,521
3,167 Added 2.63%
123,711 $7.44 Million
Q2 2021

Aug 11, 2021
BUY
$48.42 - $60.18 $45,321 - $56,328
936 Added 0.78%
120,544 $7.22 Million
Q1 2021

May 11, 2021
BUY
$47.16 - $54.44 $196,044 - $226,307
4,157 Added 3.6%
119,608 $5.95 Million
Q4 2020

Feb 11, 2021
BUY
$48.52 - $58.02 $96,603 - $115,517
1,991 Added 1.75%
115,451 $5.77 Million
Q3 2020

Nov 09, 2020
SELL
$53.07 - $61.1 $49,514 - $57,006
-933 Reduced 0.82%
113,460 $6.21 Million
Q2 2020

Aug 10, 2020
SELL
$43.1 - $55.31 $3.31 Million - $4.24 Million
-76,689 Reduced 40.13%
114,393 $6.05 Million
Q1 2020

Apr 24, 2020
BUY
$37.79 - $51.33 $3.32 Million - $4.51 Million
87,862 Added 85.12%
191,082 $8.51 Million
Q4 2019

Feb 06, 2020
BUY
$42.46 - $50.46 $511,260 - $607,588
12,041 Added 13.21%
103,220 $5.15 Million
Q3 2019

Nov 01, 2019
BUY
$40.12 - $45.47 $812,871 - $921,267
20,261 Added 28.57%
91,179 $4.06 Million
Q2 2019

Aug 08, 2019
BUY
$37.28 - $41.68 $2.54 Million - $2.84 Million
68,161 Added 2472.29%
70,918 $2.93 Million
Q1 2019

May 09, 2019
SELL
$35.49 - $43.02 $60,191 - $72,961
-1,696 Reduced 38.09%
2,757 $111,000
Q4 2018

Feb 07, 2019
BUY
$36.86 - $41.49 $17,434 - $19,624
473 Added 11.88%
4,453 $168,000
Q3 2018

Nov 01, 2018
SELL
$34.76 - $39.72 $67,017 - $76,580
-1,928 Reduced 32.63%
3,980 $159,000
Q2 2018

Aug 01, 2018
BUY
$34.55 - $37.05 $20,349 - $21,822
589 Added 11.07%
5,908 $208,000
Q1 2018

May 07, 2018
SELL
$32.97 - $36.63 $135,111 - $150,109
-4,098 Reduced 43.52%
5,319 $186,000
Q4 2017

Feb 09, 2018
BUY
$32.09 - $34.78 $302,191 - $327,523
9,417
9,417 $327,000

Others Institutions Holding AZN

# of Institutions
1,351
Shares Held
489M
Call Options Held
5.88M
Put Options Held
4.1M
View Full List

About ASTRAZENECA PLC

AZN Quotes by TradingView
  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $228B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Synovus Financial Corp Portfolio

Follow Synovus Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Synovus Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Synovus Financial Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email